{"component": "definition", "props": {"groups": [{"snippet": "means, with respect to the Compounds, all submissions to Regulatory Authorities in connection with the development of such Compounds, including all INDs and amendments thereto, NDAs and amendments thereto, drug master files, correspondence with regulatory agencies, periodic safety update reports, adverse event files, complaint files, inspection reports and manufacturing records, in each case together with all supporting documents (including documents that include Clinical Data).", "size": 178, "samples": [{"hash": "ddBiVLKu9i2", "uri": "/contracts/ddBiVLKu9i2#regulatory-documentation", "label": "Clinical Trial Collaboration and Supply Agreement (Shattuck Labs, Inc.)", "score": 34.1444206238, "published": true}, {"hash": "ljaEN1aTlqH", "uri": "/contracts/ljaEN1aTlqH#regulatory-documentation", "label": "Clinical Trial Collaboration and Supply Agreement (BioLineRx Ltd.)", "score": 33.2026023865, "published": true}, {"hash": "eKzqWUimtdb", "uri": "/contracts/eKzqWUimtdb#regulatory-documentation", "label": "Clinical Trial Collaboration and Supply Agreement (Intensity Therapeutics, Inc.)", "score": 32.8220405579, "published": true}], "snippet_links": [{"key": "with-respect-to", "type": "clause", "offset": [7, 22]}, {"key": "submissions-to-regulatory-authorities", "type": "clause", "offset": [42, 79]}, {"key": "in-connection-with", "type": "clause", "offset": [80, 98]}, {"key": "development-of", "type": "clause", "offset": [103, 117]}, {"key": "and-amendments", "type": "clause", "offset": [153, 167]}, {"key": "drug-master-files", "type": "clause", "offset": [206, 223]}, {"key": "regulatory-agencies", "type": "clause", "offset": [245, 264]}, {"key": "update-reports", "type": "clause", "offset": [282, 296]}, {"key": "adverse-event", "type": "definition", "offset": [298, 311]}, {"key": "complaint-files", "type": "clause", "offset": [319, 334]}, {"key": "inspection-reports", "type": "definition", "offset": [336, 354]}, {"key": "manufacturing-records", "type": "clause", "offset": [359, 380]}, {"key": "each-case", "type": "definition", "offset": [385, 394]}, {"key": "supporting-documents", "type": "definition", "offset": [413, 433]}, {"key": "clinical-data", "type": "definition", "offset": [468, 481]}], "hash": "cf3f490eea73dd65ee0d37c38c46a22b", "id": 1}, {"snippet": "means: all (i) applications (including all INDs and Drug Approval Applications), registrations, licenses, authorizations and approvals (including Regulatory Approvals); (ii) correspondence and reports submitted to or received from Regulatory Authorities (including minutes and official contact reports relating to any communications with any Regulatory Authority) and all supporting documents with respect thereto, including all adverse event files and complaint files; and (iii) clinical and other data contained or relied upon in any of the foregoing; in each case ((i), (ii) and (iii)) relating to the Licensed Compound or a Licensed Product.", "size": 45, "samples": [{"hash": "fqM9ElDVwT4", "uri": "/contracts/fqM9ElDVwT4#regulatory-documentation", "label": "Collaboration Agreement (Eikon Therapeutics, Inc.)", "score": 37.0219039917, "published": true}, {"hash": "12buAtZngE9", "uri": "/contracts/12buAtZngE9#regulatory-documentation", "label": "Collaboration Agreement (Eikon Therapeutics, Inc.)", "score": 36.7344284058, "published": true}, {"hash": "4ABLghGl7jn", "uri": "/contracts/4ABLghGl7jn#regulatory-documentation", "label": "Collaboration Agreement (Eikon Therapeutics, Inc.)", "score": 36.4962348938, "published": true}], "snippet_links": [{"key": "inds-and-drug-approval-applications", "type": "clause", "offset": [43, 78]}, {"key": "authorizations-and-approvals", "type": "clause", "offset": [106, 134]}, {"key": "regulatory-approvals", "type": "clause", "offset": [146, 166]}, {"key": "regulatory-authorities", "type": "clause", "offset": [231, 253]}, {"key": "contact-reports", "type": "clause", "offset": [286, 301]}, {"key": "relating-to", "type": "definition", "offset": [302, 313]}, {"key": "regulatory-authority", "type": "definition", "offset": [342, 362]}, {"key": "supporting-documents", "type": "definition", "offset": [372, 392]}, {"key": "adverse-event", "type": "definition", "offset": [429, 442]}, {"key": "complaint-files", "type": "clause", "offset": [453, 468]}, {"key": "other-data", "type": "clause", "offset": [493, 503]}, {"key": "the-foregoing", "type": "definition", "offset": [539, 552]}, {"key": "each-case", "type": "definition", "offset": [557, 566]}, {"key": "licensed-compound", "type": "definition", "offset": [605, 622]}, {"key": "licensed-product", "type": "definition", "offset": [628, 644]}], "hash": "219c984c070a5877201e1c7342319e58", "id": 2}, {"snippet": "means all (a) applications (including all INDs and Drug Approval Applications), registrations, licenses, authorizations and approvals (including all Market Approvals), (b) correspondence and reports submitted to or received from Regulatory Authorities (including minutes and official contact reports relating to any communications with any Regulatory Authority) and all supporting documents with respect thereto, including all regulatory drug lists, advertising and promotion documents, Adverse Event files and complaint files and (c) Clinical Data and any other data contained in any of the foregoing, in each case ((a), (b) and (c)), relating to the Licensed Product.", "size": 43, "samples": [{"hash": "fTPKoTHFIML", "uri": "/contracts/fTPKoTHFIML#regulatory-documentation", "label": "License Agreement (Kardigan, Inc.)", "score": 37.3367538452, "published": true}, {"hash": "eSONFzjGTpk", "uri": "/contracts/eSONFzjGTpk#regulatory-documentation", "label": "Joint Development and License Agreement (Alto Neuroscience, Inc.)", "score": 34.9876785278, "published": true}, {"hash": "62UigPmAr3u", "uri": "/contracts/62UigPmAr3u#regulatory-documentation", "label": "License Agreement (Alto Neuroscience, Inc.)", "score": 34.9876785278, "published": true}], "snippet_links": [{"key": "inds-and-drug-approval-applications", "type": "clause", "offset": [42, 77]}, {"key": "authorizations-and-approvals", "type": "clause", "offset": [105, 133]}, {"key": "regulatory-authorities", "type": "clause", "offset": [229, 251]}, {"key": "contact-reports", "type": "clause", "offset": [284, 299]}, {"key": "relating-to", "type": "definition", "offset": [300, 311]}, {"key": "regulatory-authority", "type": "definition", "offset": [340, 360]}, {"key": "supporting-documents", "type": "definition", "offset": [370, 390]}, {"key": "advertising-and-promotion", "type": "definition", "offset": [450, 475]}, {"key": "adverse-event", "type": "definition", "offset": [487, 500]}, {"key": "complaint-files", "type": "clause", "offset": [511, 526]}, {"key": "clinical-data", "type": "definition", "offset": [535, 548]}, {"key": "other-data", "type": "clause", "offset": [557, 567]}, {"key": "contained-in", "type": "definition", "offset": [568, 580]}, {"key": "the-foregoing", "type": "definition", "offset": [588, 601]}, {"key": "each-case", "type": "definition", "offset": [606, 615]}, {"key": "licensed-product", "type": "definition", "offset": [652, 668]}], "hash": "4ab0ef6c666adc3eb6078319a295bc1c", "id": 3}, {"snippet": "means any and all (a) applications, registrations, licenses, authorizations and approvals (including Regulatory Approvals); and (b) correspondence, reports and other submissions submitted to or received from Regulatory Authorities and all supporting documents with respect thereto, including all adverse event files and complaint files.", "size": 36, "samples": [{"hash": "hpZqCTuqu3Z", "uri": "/contracts/hpZqCTuqu3Z#regulatory-documentation", "label": "Commercialization Agreement (Beta Bionics, Inc)", "score": 36.0143737793, "published": true}, {"hash": "dZT9m0aWUGA", "uri": "/contracts/dZT9m0aWUGA#regulatory-documentation", "label": "Commercialization Agreement (Beta Bionics, Inc)", "score": 35.9568786621, "published": true}, {"hash": "bCFreVHni8g", "uri": "/contracts/bCFreVHni8g#regulatory-documentation", "label": "Commercialization Agreement (Beta Bionics, Inc)", "score": 35.8227233887, "published": true}], "snippet_links": [{"key": "authorizations-and-approvals", "type": "clause", "offset": [61, 89]}, {"key": "regulatory-approvals", "type": "clause", "offset": [101, 121]}, {"key": "other-submissions", "type": "clause", "offset": [160, 177]}, {"key": "regulatory-authorities", "type": "clause", "offset": [208, 230]}, {"key": "supporting-documents", "type": "definition", "offset": [239, 259]}, {"key": "adverse-event", "type": "definition", "offset": [296, 309]}, {"key": "complaint-files", "type": "clause", "offset": [320, 335]}], "hash": "f5e409260345f63f88df2251de0d7415", "id": 4}, {"snippet": "means all (i) applications (including all INDs and Drug Approval Applications), registrations, licenses, authorizations, and approvals (including Regulatory Approvals); (ii) correspondence and reports submitted to or received from Regulatory Authorities (including minutes and official contact reports relating to any communications with any Regulatory Authority) and all supporting documents with respect thereto, including all regulatory drug lists, advertising and promotion documents, adverse event files, and complaint files; and (iii) clinical and other data contained or relied upon in any of the foregoing, in each case ((i), (ii), and (iii)) relating to a Product.", "size": 35, "samples": [{"hash": "1SbIHWop23B", "uri": "/contracts/1SbIHWop23B#regulatory-documentation", "label": "License Agreement (Point of Care Nano-Technology, Inc.)", "score": 35.4394264221, "published": true}, {"hash": "8sIYHADQohi", "uri": "/contracts/8sIYHADQohi#regulatory-documentation", "label": "License Agreement (Emergent BioSolutions Inc.)", "score": 30.1416835785, "published": true}, {"hash": "3JerXTLerfd", "uri": "/contracts/3JerXTLerfd#regulatory-documentation", "label": "License Agreement (Opiant Pharmaceuticals, Inc.)", "score": 29.1724853516, "published": true}], "snippet_links": [{"key": "inds-and-drug-approval-applications", "type": "clause", "offset": [42, 77]}, {"key": "regulatory-approvals", "type": "clause", "offset": [146, 166]}, {"key": "regulatory-authorities", "type": "clause", "offset": [231, 253]}, {"key": "contact-reports", "type": "clause", "offset": [286, 301]}, {"key": "relating-to", "type": "definition", "offset": [302, 313]}, {"key": "regulatory-authority", "type": "definition", "offset": [342, 362]}, {"key": "supporting-documents", "type": "definition", "offset": [372, 392]}, {"key": "advertising-and-promotion", "type": "definition", "offset": [452, 477]}, {"key": "adverse-event", "type": "definition", "offset": [489, 502]}, {"key": "complaint-files", "type": "clause", "offset": [514, 529]}, {"key": "other-data", "type": "clause", "offset": [554, 564]}, {"key": "the-foregoing", "type": "definition", "offset": [600, 613]}, {"key": "each-case", "type": "definition", "offset": [618, 627]}], "hash": "9cd7384bcf96d36cddc74fdec249ecc3", "id": 5}, {"snippet": "means all applications, registrations, licenses, authorizations and approvals, all correspondence submitted to or received from Regulatory Health Authorities (including minutes and official contact reports relating to any communications with any Regulatory Health Authority) and all supporting documents, including documentation arising in the course of all clinical studies and tests, in each case relating to any Program Compounds or Program Products, including all INDs, Regulatory Approvals, regulatory drug lists, advertising and promotion documents, adverse event files and complaint files.", "size": 35, "samples": [{"hash": "jKFraRng5JU", "uri": "/contracts/jKFraRng5JU#regulatory-documentation", "label": "License Agreement (Ardelyx, Inc.)", "score": 25.4243659973, "published": true}, {"hash": "HjNqQ1ZvHq", "uri": "/contracts/HjNqQ1ZvHq#regulatory-documentation", "label": "License Agreement (Ardelyx, Inc.)", "score": 25.377822876, "published": true}, {"hash": "fpSnyR4Gu2N", "uri": "/contracts/fpSnyR4Gu2N#regulatory-documentation", "label": "License Agreement (Ardelyx, Inc.)", "score": 25.2737846375, "published": true}], "snippet_links": [{"key": "authorizations-and-approvals", "type": "clause", "offset": [49, 77]}, {"key": "health-authorities", "type": "definition", "offset": [139, 157]}, {"key": "contact-reports", "type": "clause", "offset": [190, 205]}, {"key": "relating-to", "type": "definition", "offset": [206, 217]}, {"key": "regulatory-health-authority", "type": "definition", "offset": [246, 273]}, {"key": "supporting-documents", "type": "definition", "offset": [283, 303]}, {"key": "in-the-course-of", "type": "definition", "offset": [337, 353]}, {"key": "studies-and-tests", "type": "clause", "offset": [367, 384]}, {"key": "each-case", "type": "definition", "offset": [389, 398]}, {"key": "program-compounds", "type": "definition", "offset": [415, 432]}, {"key": "program-products", "type": "definition", "offset": [436, 452]}, {"key": "regulatory-approvals", "type": "clause", "offset": [474, 494]}, {"key": "advertising-and-promotion", "type": "definition", "offset": [519, 544]}, {"key": "adverse-event", "type": "definition", "offset": [556, 569]}, {"key": "complaint-files", "type": "clause", "offset": [580, 595]}], "hash": "c3e55c6fa89a14622010b1586f2181ff", "id": 6}, {"snippet": "means all (a) applications (including all INDs), registrations, licenses, authorizations and approvals (including Regulatory Approvals), (b) correspondence and reports submitted to or received from Regulatory Authorities (including minutes and official contact reports relating to any communications with any Regulatory Authority) and all supporting documents with respect thereto, including all adverse event files and complaint files, (c) clinical and other data contained, referenced or otherwise relied upon in any of the foregoing, and (d) for clarity, any Drug Master File.", "size": 32, "samples": [{"hash": "lMQKAYAgBVc", "uri": "/contracts/lMQKAYAgBVc#regulatory-documentation", "label": "Multi Target Collaboration and License Agreement (Molecular Templates, Inc.)", "score": 28.7919235229, "published": true}, {"hash": "39usDv12blq", "uri": "/contracts/39usDv12blq#regulatory-documentation", "label": "Multi Target Collaboration and License Agreement (Molecular Templates, Inc.)", "score": 28.597536087, "published": true}], "snippet_links": [{"key": "authorizations-and-approvals", "type": "clause", "offset": [74, 102]}, {"key": "regulatory-approvals", "type": "clause", "offset": [114, 134]}, {"key": "regulatory-authorities", "type": "clause", "offset": [198, 220]}, {"key": "contact-reports", "type": "clause", "offset": [253, 268]}, {"key": "relating-to", "type": "definition", "offset": [269, 280]}, {"key": "regulatory-authority", "type": "definition", "offset": [309, 329]}, {"key": "supporting-documents", "type": "definition", "offset": [339, 359]}, {"key": "adverse-event", "type": "definition", "offset": [396, 409]}, {"key": "complaint-files", "type": "clause", "offset": [420, 435]}, {"key": "other-data", "type": "clause", "offset": [454, 464]}, {"key": "the-foregoing", "type": "definition", "offset": [522, 535]}, {"key": "for-clarity", "type": "clause", "offset": [545, 556]}, {"key": "drug-master-file", "type": "definition", "offset": [562, 578]}], "hash": "1a65f0a8a923aa8a7daf25193b43dbda", "id": 7}, {"snippet": "means all applications, registrations, licenses, authorizations and approvals (including all Regulatory Approvals), all correspondence submitted to or received from Regulatory Authorities (including minutes and official contact reports relating to any communications with any Regulatory Authority), all supporting documents and all clinical studies and tests, including the manufacturing batch records, relating to the Product, and all data contained in any of the foregoing, including all regulatory drug lists, advertising and promotion documents, adverse event files and complaint files.", "size": 27, "samples": [{"hash": "kw4pbGlknFt", "uri": "/contracts/kw4pbGlknFt#regulatory-documentation", "label": "License Agreement (Isis Pharmaceuticals Inc)", "score": 21.0, "published": true}, {"hash": "kYnOyh52Jb2", "uri": "/contracts/kYnOyh52Jb2#regulatory-documentation", "label": "Collaboration and Co Development Agreement (Oncogenex Technologies Inc)", "score": 21.0, "published": true}, {"hash": "jTjSIeGcG9J", "uri": "/contracts/jTjSIeGcG9J#regulatory-documentation", "label": "Collaboration and License Agreement (Oncogenex Technologies Inc)", "score": 21.0, "published": true}], "snippet_links": [{"key": "authorizations-and-approvals", "type": "clause", "offset": [49, 77]}, {"key": "regulatory-approvals", "type": "clause", "offset": [93, 113]}, {"key": "regulatory-authorities", "type": "clause", "offset": [165, 187]}, {"key": "contact-reports", "type": "clause", "offset": [220, 235]}, {"key": "relating-to", "type": "definition", "offset": [236, 247]}, {"key": "regulatory-authority", "type": "definition", "offset": [276, 296]}, {"key": "supporting-documents", "type": "definition", "offset": [303, 323]}, {"key": "studies-and-tests", "type": "clause", "offset": [341, 358]}, {"key": "manufacturing-batch-records", "type": "clause", "offset": [374, 401]}, {"key": "the-product", "type": "clause", "offset": [415, 426]}, {"key": "contained-in", "type": "definition", "offset": [441, 453]}, {"key": "the-foregoing", "type": "definition", "offset": [461, 474]}, {"key": "advertising-and-promotion", "type": "definition", "offset": [513, 538]}, {"key": "adverse-event", "type": "definition", "offset": [550, 563]}, {"key": "complaint-files", "type": "clause", "offset": [574, 589]}], "hash": "2088c6c48de7a6d37efd4160ef57de84", "id": 8}, {"snippet": "means all (a) applications (including all INDs and Drug Approval Applications and other regulatory filings), registrations, licenses, authorizations, and approvals (including Regulatory Approvals); (b) correspondence and reports submitted to or received from Regulatory Authorities (including minutes and official contact reports relating to any communications with any Regulatory Authority) and all supporting documents with respect thereto, including all regulatory drug lists, advertising and promotion documents, adverse event files, and complaint files; and (c) pre-clinical and clinical data, and data contained or relied upon in any of the foregoing, in each case (a), (b), and (c) relating to Product.", "size": 21, "samples": [{"hash": "7WnTaLKXFQE", "uri": "/contracts/7WnTaLKXFQE#regulatory-documentation", "label": "Early Access Agreement (Hemispherx Biopharma Inc)", "score": 28.3483905792, "published": true}, {"hash": "57Y6mJWnU88", "uri": "/contracts/57Y6mJWnU88#regulatory-documentation", "label": "Early Access Agreement (Hemispherx Biopharma Inc)", "score": 28.0444908142, "published": true}, {"hash": "bDsRuCCF1Yb", "uri": "/contracts/bDsRuCCF1Yb#regulatory-documentation", "label": "Early Access Agreement (Hemispherx Biopharma Inc)", "score": 26.8726902008, "published": true}], "snippet_links": [{"key": "inds-and-drug-approval-applications", "type": "clause", "offset": [42, 77]}, {"key": "other-regulatory-filings", "type": "clause", "offset": [82, 106]}, {"key": "regulatory-approvals", "type": "clause", "offset": [175, 195]}, {"key": "regulatory-authorities", "type": "clause", "offset": [259, 281]}, {"key": "contact-reports", "type": "clause", "offset": [314, 329]}, {"key": "relating-to", "type": "definition", "offset": [330, 341]}, {"key": "regulatory-authority", "type": "definition", "offset": [370, 390]}, {"key": "supporting-documents", "type": "definition", "offset": [400, 420]}, {"key": "advertising-and-promotion", "type": "definition", "offset": [480, 505]}, {"key": "adverse-event", "type": "definition", "offset": [517, 530]}, {"key": "complaint-files", "type": "clause", "offset": [542, 557]}, {"key": "clinical-data", "type": "definition", "offset": [584, 597]}, {"key": "the-foregoing", "type": "definition", "offset": [643, 656]}, {"key": "each-case", "type": "definition", "offset": [661, 670]}], "hash": "fbe2b855c70d075304aa219b99de9e0b", "id": 9}, {"snippet": "means, with respect to the Collaboration, all INDs, NDAs and other regulatory applications submitted to any Regulatory Authority, Regulatory Approvals, pre-clinical and clinical data and information, regulatory materials, drug dossiers, master files (including Drug Master Files, as defined in 21 C.F.R. 314.420 and any non-United States equivalents), and any other data, reports, records, regulatory correspondence and other materials relating to Development or Regulatory Approval of the Licensed Products, or required to Manufacture, distribute or sell the Licensed Products, including any information that relates to pharmacology, toxicology, chemistry, Manufacturing and controls data, batch records, safety and efficacy, and any safety database.", "size": 19, "samples": [{"hash": "9GLdmDC2Q3U", "uri": "/contracts/9GLdmDC2Q3U#regulatory-documentation", "label": "Master Research and Collaboration Agreement (Agios Pharmaceuticals Inc)", "score": 27.6009578705, "published": true}, {"hash": "79bJLt8jhIW", "uri": "/contracts/79bJLt8jhIW#regulatory-documentation", "label": "Collaboration and License Agreement (Agios Pharmaceuticals Inc)", "score": 26.5961666107, "published": true}, {"hash": "5GbtkIMl9Bl", "uri": "/contracts/5GbtkIMl9Bl#regulatory-documentation", "label": "Collaboration and License Agreement (Agios Pharmaceuticals Inc)", "score": 26.5961666107, "published": true}], "snippet_links": [{"key": "with-respect-to", "type": "clause", "offset": [7, 22]}, {"key": "the-collaboration", "type": "clause", "offset": [23, 40]}, {"key": "regulatory-applications", "type": "definition", "offset": [67, 90]}, {"key": "regulatory-authority", "type": "definition", "offset": [108, 128]}, {"key": "regulatory-approvals", "type": "clause", "offset": [130, 150]}, {"key": "data-and-information", "type": "clause", "offset": [178, 198]}, {"key": "regulatory-materials", "type": "clause", "offset": [200, 220]}, {"key": "drug-master-files", "type": "clause", "offset": [261, 278]}, {"key": "any-non", "type": "clause", "offset": [316, 323]}, {"key": "united-states", "type": "definition", "offset": [324, 337]}, {"key": "other-data", "type": "clause", "offset": [360, 370]}, {"key": "regulatory-correspondence", "type": "definition", "offset": [390, 415]}, {"key": "other-materials", "type": "clause", "offset": [420, 435]}, {"key": "to-development", "type": "clause", "offset": [445, 459]}, {"key": "approval-of", "type": "definition", "offset": [474, 485]}, {"key": "licensed-products", "type": "definition", "offset": [490, 507]}, {"key": "to-manufacture", "type": "definition", "offset": [521, 535]}, {"key": "distribute-or-sell", "type": "definition", "offset": [537, 555]}, {"key": "relates-to", "type": "definition", "offset": [610, 620]}, {"key": "batch-records", "type": "definition", "offset": [691, 704]}, {"key": "safety-and-efficacy", "type": "clause", "offset": [706, 725]}, {"key": "safety-database", "type": "definition", "offset": [735, 750]}], "hash": "904f6a180b420cf86e3d39935830bfbd", "id": 10}], "next_curs": "CmUSX2oVc35sYXdpbnNpZGVyY29udHJhY3RzckELEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIhcmVndWxhdG9yeS1kb2N1bWVudGF0aW9uIzAwMDAwMDBhDKIBAmVuGAAgAA==", "definition": {"snippet": "means, with respect to the Compounds, all submissions to Regulatory Authorities in connection with the development of such Compounds, including all INDs and amendments thereto, NDAs and amendments thereto, drug master files, correspondence with regulatory agencies, periodic safety update reports, adverse event files, complaint files, inspection reports and manufacturing records, in each case together with all supporting documents (including documents that include Clinical Data).", "size": 1352, "title": "Regulatory Documentation", "id": "regulatory-documentation", "examples": ["Neither Iambic nor any of its Affiliates have submitted any <strong>Regulatory Documentation</strong> to, or communicated with, any Regulatory Authority in connection with any such Qualifying Compound.", "All <strong>Regulatory Documentation</strong> (including all Regulatory Approvals) in the Territory relating to the Qualifying Compounds or Qualifying Products shall be owned by, and shall be the sole property and held in the name of, Takeda or its designated Affiliate, Sublicensee or designee.", "The Parties do not anticipate that any <strong>Regulatory Documentation</strong> will be submitted to or received from any Regulatory Authority with respect to any Collaboration Program prior to the corresponding License Effective Date.", "Notwithstanding any other provision of this Section 12.9 (Transition Agreement and Other Performance Obligations), AbbVie shall have no obligation to grant to Iambic any license or other right under Information, Regulatory Approvals or <strong>Regulatory Documentation</strong> Controlled by AbbVie, in each case, related to the Manufacture of Licensed Compounds or Licensed Products.", "All <strong>Regulatory Documentation</strong> (including all Trial Master Files, Regulatory Approvals, Product Labeling and INDs) relating to the applicable Licensed Compounds or Licensed Products in the Territory shall be owned by, and shall be the sole property and held in the name of, AbbVie or its Affiliate, Sublicensee or its or their designee.", "Notwithstanding the foregoing, if a Party believes that <strong>Regulatory Documentation</strong> will be submitted to, or receives <strong>Regulatory Documentation</strong> from, a Regulatory Authority prior to the applicable License Effective Date, such Party shall notify the other Party thereof and the Parties shall discuss in good faith and agree on next steps with respect thereto."], "related": [["regulatory-documents", "Regulatory Documents", "Regulatory Documents"], ["regulatory-materials", "Regulatory Materials", "Regulatory Materials"], ["regulatory-filing", "Regulatory Filing", "Regulatory Filing"], ["regulatory-filings", "Regulatory Filings", "Regulatory Filings"], ["regulatory-data", "Regulatory Data", "Regulatory Data"]], "related_snippets": [], "updated": "2026-11-07T04:22:58+00:00"}, "json": true, "cursor": ""}}